We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Cross-Checking between ED Physicians Reduces Harm

By HospiMedica International staff writers
Posted on 08 May 2018
Image: A new study suggests a few minutes of consultation can avoid adverse ED events (Photo courtesy of Dreamstime).
Image: A new study suggests a few minutes of consultation can avoid adverse ED events (Photo courtesy of Dreamstime).
A new study suggests that systematic cross-checking between doctors may be a key to reducing the high rate of adverse events in the emergency department (ED).

Researchers at the Sorbonne University (Paris, France), Pitie-Salpetriere Hospital (Paris, France), and other institutions conducted a cluster randomized crossover trial that included a random sample of 1,680 patients attended to in six EDs in France during two 10-day periods. The intervention included systematic cross-checking between ED physicians three times a day, which included a brief presentation of one physician’s case to another, followed by the second physician’s feedback. The main outcome was medical error, defined as either a near miss or a serious adverse event.

The results showed that there were 54 adverse events among 840 patients (6.4%) during the cross-check intervention, compared with 90 adverse events among 840 patients (10.7%) during the control period, a relative reduction of 40%. Most of the reductions occurred in adverse events defined as near misses, with a reduction of 47%. Errors in sepsis management accounted for more than 40% of the preventable serious adverse events. The median duration of cross-checking sessions was nine minutes, during which about seven patients were discussed. The study was published on April 23, 2018, in JAMA Internal Medicine.

“The reduction in preventable serious adverse events with systematic cross-checking did not reach statistical significance; only reductions in near misses did,” explained lead author Yonathan Freund, MD, PhD, of Hôpital Pitié-Salpêtrière. “Whether an adverse event resulted from a misdiagnosis or from the implementation of an inappropriate plan for the correct diagnosis could not be determined decisively. This included sepsis-associated medical errors, which may be particularly relevant, because the most commonly occurring serious adverse events were violations of the surviving sepsis campaign guidelines.”

An adverse event is defined as a preventable or non-preventable injury that was caused by medical management (rather than the underlying disease) and that prolonged hospitalization, produced a disability at the time of discharge, or both. Adverse event also include errors, defined as acts of commission or omission leading to an undesirable outcome or significant potential for such an outcome, and near misses, in which an error was committed, but the patient did not experience clinical harm, either through early detection or sheer luck.

Related Links:
Sorbonne University
Pitie-Salpetriere Hospital

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Half Apron
Demi
New
Lateral Lumbar Interbody Spacer
CALIBER-L

Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more